PMID- 17445011 OWN - NLM STAT- MEDLINE DCOM- 20070702 LR - 20101118 IS - 1445-5994 (Electronic) IS - 1444-0903 (Linking) VI - 37 IP - 7 DP - 2007 Jul TI - Results of primary percutaneous coronary intervention in a consecutive group of patients with acute ST elevation myocardial infarction at a tertiary Australian centre. PG - 464-71 AB - BACKGROUND: Multicentre randomized controlled trials (RCT) of primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) have consistently shown lower mortality compared with fibrinolysis, if carried out in a timely manner. Although primary PCI is now standard of care in many centres, it remains unknown whether results from RCT of selected patients are generalizable to a 'real-world' Australian setting. The primary goal of this study was to evaluate whether a strategy of routine invasive management for patients with STEMI can achieve 30-day and 12-month mortality rates comparable with multicentre RCT. Secondary goals were to determine 30-day mortality rates in prespecified high-risk subgroups, and symptom-onset- and door-to-balloon-inflation times. METHODS: A retrospective observational study of 189 consecutive patients treated with primary PCI for STEMI in a single Australian centre performing PCI for acute STEMI. RESULTS: All-cause mortality was 6.9% at 30 days, and 10.4% at 12 months. Mortality in patients presenting without cardiogenic shock was low (2.4% at 30 days; 5.0% at 12 months), whereas 12-month mortality in patients with shock was higher, particularly in the elderly (29.4% for patients <75 years; 85.7% for patients > or =75 years, P = 0.01). Symptom-onset-to-balloon-inflation time was < or =4 h in 56% of patients (median 231 min); however, a door-to-balloon time of <90 min was achieved in only 20% (median 133 min). CONCLUSION: Mortality and symptom-onset-to-balloon-inflation times reported in RCT of primary PCI for STEMI are generalizable to 'real-world' Australian practice; however, further efforts to reduce door-to-balloon times are required. FAU - van Gaal, W J AU - van Gaal WJ AD - Department of Cardiology, The John Radcliffe, Oxford, United Kingdom. bill.vangaal@conted.ox.ac.uk FAU - Clark, D AU - Clark D FAU - Barlis, P AU - Barlis P FAU - Lim, C C S AU - Lim CC FAU - Johns, J AU - Johns J FAU - Horrigan, M AU - Horrigan M LA - eng PT - Clinical Trial PT - Journal Article PT - Randomized Controlled Trial DEP - 20070416 PL - Australia TA - Intern Med J JT - Internal medicine journal JID - 101092952 SB - IM MH - Aged MH - *Angioplasty, Balloon, Coronary MH - Australia MH - Electrocardiography MH - Female MH - Humans MH - Male MH - Middle Aged MH - Multicenter Studies as Topic MH - Myocardial Infarction/diagnosis/*mortality/*therapy MH - Thrombolytic Therapy/*mortality MH - Treatment Outcome EDAT- 2007/04/21 09:00 MHDA- 2007/07/03 09:00 CRDT- 2007/04/21 09:00 PHST- 2007/04/21 09:00 [pubmed] PHST- 2007/07/03 09:00 [medline] PHST- 2007/04/21 09:00 [entrez] AID - IMJ1357 [pii] AID - 10.1111/j.1445-5994.2007.01357.x [doi] PST - ppublish SO - Intern Med J. 2007 Jul;37(7):464-71. doi: 10.1111/j.1445-5994.2007.01357.x. Epub 2007 Apr 16.